Lineage Biosciences Overview

  • Founded
  • 2014
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Lineage Biosciences General Information

Description

Developer of an antibody discovery technology intended to profile antibody responses using sequencing of immunoglobulin genes. The company's technology provides deep analysis of antibodies generated by natural immune responses during infection, autoimmune disease, cancer, immunization and vaccination, enabling the medical industry to develop vaccines and to accelerate antibody discovery.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • 3183 Porter Drive
  • Palo Alto, CA 94304
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Lineage Biosciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Lineage Biosciences‘s full profile, request access.

Request a free trial

Lineage Biosciences Executive Team (1)

Name Title Board Seat Contact Info
Bruce Hironaka President
To view Lineage Biosciences’s complete executive team members history, request access »